Mitsubishi UFJ Capital

RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a specialized radiation therapy that uses nuclear reactions between neutrons and boron-10 to destroy cancer cells.

United Immunity, Co., Ltd. is a research and development company based in Tsu, Japan, specializing in the manufacture and sales of pharmaceuticals with a primary focus on cancer immunotherapy. Founded in November 2017, the company develops innovative nanoparticles and lipid nanoparticles aimed at targeting myeloid cells to treat cancer and infectious diseases. United Immunity's technology enables the delivery of various therapeutic agents directly to macrophages and dendritic cells, facilitating the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases.

Founded in 2015, Ball Wave specializes in developing and manufacturing sensors. Its product portfolio includes trace moisture sensors, mini sensors, and ball surface acoustic waves gas sensors.

Stem Cell & Device Laboratory, Inc. is a research and development company based in Kyoto, Japan, focused on the manufacturing and sale of cells, devices, and integrated products that utilize cell materials for drug discovery applications. Founded in 2014, the company specializes in developing innovative scaffold materials that demonstrate functional and cell compatibility, particularly for studies involving pluripotent stem cells. By leveraging advanced micro-engineering and nanofabrication technologies, Stem Cell & Device Laboratory aims to contribute to advancements in cell application products that support the health and well-being of society.

NanoMist Technologies engages with R&D, design, and sells machines in the areas such as alcoholic beverages and food enrichment, fragrance extraction, chemical purification process, wastewater management, and deodorization process. NanoMist Technologies manufactures and sells machines such as ultrasonic atomization machine, deodorization machine, hot spring water concentration machine, solvent recovery machine, VOCs recovery machine, and granular material production machine.

Cambrios Technologies Corporation is a manufacturer of innovative electronic materials specializing in silver nanowire-based electrodes. Founded in 2002 and originally named Semzyme, Inc., the company rebranded in August 2004. Headquartered in Sunnyvale, California, with additional offices in Japan and Taiwan, Cambrios develops products such as ClearOhm, which are transparent conductive coatings that can be applied to various substrates for multiple applications. These include touch screens, liquid crystal displays, e-paper, OLED devices, and lighting, as well as thin film photovoltaics like organic photovoltaics and printed organic solar cells. Cambrios's technology enables simplified manufacturing processes and enhances the performance of next-generation consumer devices.

NeoPhotonics is a technology company specializing in the development, manufacture, and sale of optical components and subsystems used in high-speed digital communications networks. The company offers a comprehensive range of active and passive optical products tailored for various market segments, including fiber-to-the-home (FTTH), data communications, storage area networks, and both metro and long-haul networks. Its product lineup includes transceivers, integrated splitters, multiplexers, and advanced optical modules, all designed to support a wide array of data rates and applications. Notably, NeoPhotonics is recognized for its innovative silica Planar Lightwave Circuit (PLC) technology, which plays a crucial role in modern optical networks. Additionally, the company produces MEMS-based Variable Optical Attenuators and Dynamic Channel Equalizers, enhancing the performance and efficiency of communication systems.

Nanotech Partners is a private equity firm established in September 2001, specializing in investments within the nanotechnology sector globally. Sponsored by Mitsubishi Corporation, the firm aims to generate long-term capital gains by identifying and supporting emerging nanotechnology businesses with significant growth potential. Investors in Nanotech Partners include Mitsubishi Corporation, Mitsubishi Chemical Corporation, and Honjo Chemical Corporation. The firm's unique focus on nanotechnology allows it to leverage valuable insights into technology and commercialization, fostering innovation and development in this advanced field. Nanotech Partners is managed by a team that collaborates with local offices of Mitsubishi Corporation to enhance its investment strategies and execution.